News + Filings Holdings
|
Essex Woodlands Management, Inc.
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 457,085 | 0 | 11,568,821,000 | -3,153,887,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 457,085 | 0 | 14,722,708,000 | 14,710,367,000 | $32,210.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 457,085 | 0 | 12,341,000 | 6,024,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 457,085 | 0 | 6,317,000 | -2,596,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 457,085 | -15,505 | 8,913,000 | -4,253,000 | $19.50 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 472,590 | -861,102 | 13,166,000 | -24,111,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 1,333,692 | -2,008,355 | 37,277,000 | -57,437,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 94,714,000 | 10,695,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 84,019,000 | 2,406,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 81,613,000 | 32,151,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 49,462,000 | -4,779,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 54,241,000 | 10,794,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 43,447,000 | 101,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 43,346,000 | -9,325,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 52,671,000 | -39,068,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 91,739,000 | 8,689,000 | $27.45 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | 0 | 83,050,000 | -8,689,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 3,342,047 | -500,000 | 91,739,000 | -26,596,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 3,842,047 | 0 | 118,335,000 | -19,018,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 3,842,047 | -750,000 | 137,353,000 | 10,842,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 126,511,000 | 5,281,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 121,230,000 | 25,715,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 95,515,000 | 460,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 95,055,000 | 20,618,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 74,437,000 | 11,985,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 62,452,000 | 62,452,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 80,177,000 | 80,177,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 156,864,000 | 10,010,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 0 | 136,659,000 | -10,195,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 146,854,000 | 146,854,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 95,193,000 | 95,193,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 77,789,000 | 77,789,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 88,764,000 | 88,764,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 156,130,000 | 156,130,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 4,592,047 | 4,592,047 | 144,649,000 | 144,649,000 | $31.50 |
| << Prev Next >> |
|